NSE shareholding pattern
Jubilant Pharmova Limited shareholding pattern
As of the Sep 2026 shareholding pattern (quarter ended 2026-09-30), promoters held 47.68%, FIIs 15.37%, and DIIs 13.01% of Jubilant Pharmova Limited (JUBLPHARMA). Against the Jun 2026 pattern, FII holding is down 0.5 percentage points (15.87% → 15.37%), DII up 0.61 points (12.4% → 13.01%), and promoter holding unchanged at 47.68%. The table below shows how promoter, FII, DII and public holding has moved quarter by quarter, taken from the NSE shareholding pattern.
Smart Money Report, Q2 FY27: shareholding patterns for the quarter ended 30 Sep 2026
Definition
A shareholding pattern is the quarterly breakdown of who owns a listed company, split across promoters, foreign institutional investors (FII), domestic institutional investors (DII), and the public. Indian companies file it every quarter under SEBI listing rules. Source: NSE shareholding pattern.
Jubilant Pharmova Limited shareholding by quarter
| Quarter | Promoter % | FII % | DII % | Public % | Filed |
|---|---|---|---|---|---|
| Sep 2026 | 47.68 | 15.37 | 13.01 | 23.94 | 2026-09-30 |
| Jun 2026 | 47.68 | 15.87 | 12.4 | 24.05 | 2026-06-30 |
| Mar 2026 | 47.68 | 15.9 | 11.63 | 24.79 | 2026-03-31 |
| Dec 2025 | 47.68 | 15.96 | 11.23 | 25.13 | 2025-12-31 |
| Sep 2025 | 47.68 | 16.56 | 10.53 | 25.23 | 2025-09-30 |
| Jun 2025 | 47.68 | 17.4 | 9.52 | 25.4 | 2025-06-30 |
Disclosures shown are public regulatory filings. Data may be delayed or incomplete. Smart-money entities may no longer hold positions shown. Not investment advice.
Disclosure overlap on Jubilant Pharmova Limited
6 independent managers6 independent managers disclosed positions in Jubilant Pharmova Limited within the same window (Jul 14, 2026 – Oct 12, 2026), per filings across sources. Who they are — and each underlying filing — is shown inside Flock.
A count of what was filed, per public regulatory filings. Not investment advice.
Related on Flock
- Smart money moves this filing week (insider trades, bulk deals and stake disclosures from the last 7 days)
- All NSE shareholding patterns (browse every company by name)
- What is a 13F filing? (how the US equivalent disclosure works)
- FII and DII activity, sourced and dated
- Today's NSE and BSE bulk and block deals
- Shareholding patterns for other companies in the same industry: Laurus Labs Limited, Lupin Limited, Mankind Pharma Limited, Marksans Pharma Limited, Natco Pharma Limited, Neuland Laboratories Limited, Onesource Specialty Pharma Limited, Pfizer Limited
- When smart money's filings overlap (multi-entity disclosure overlap, explained)
Frequently asked questions
What is the promoter holding in Jubilant Pharmova Limited?
As of the Sep 2026 shareholding pattern, promoters held 47.68% of Jubilant Pharmova Limited (JUBLPHARMA). Figures are taken from the NSE shareholding pattern filing dated 2026-09-30 and may change each quarter. Not investment advice.
What is the FII holding in Jubilant Pharmova Limited?
Foreign institutional investors held 15.37% of Jubilant Pharmova Limited as of the Sep 2026 pattern, versus 15.87% in the Jun 2026 pattern. Source: NSE shareholding pattern, quarter ended 2026-09-30. Not investment advice.
How much did FII holding in Jubilant Pharmova Limited change in the Sep 2026 quarter?
FII holding in Jubilant Pharmova Limited was 15.87% in the Jun 2026 pattern and 15.37% in Sep 2026, a difference of 0.5 percentage points down. Promoter holding was unchanged at 47.68% across the two filings, and both figures are percentages as filed. Source: NSE shareholding pattern, quarter ended 2026-09-30. Not investment advice.
How often is the shareholding pattern updated?
Listed Indian companies disclose their shareholding pattern every quarter under SEBI's listing rules. Flock re-stamps each page when a new quarterly pattern is filed, so the freshness chip reflects the true age of the latest data.
The Smart Money Digest
A free weekly email of notable disclosure activity — every line with its filing date and source link. No advice, just filings. Unsubscribe anytime.